Evidence map›Paper›PMID 37902550›Full record

ArticleCancer discovery2024

GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress.

Weihua Zhou, Zitong Zhao, Angelica Lin, John Z Yang, Jie Xu, Kari Wilder-Romans, Annabel Yang, Jing Li, Sumeet Solanki, Jennifer M Speth and 30 more

Open access · greenAbstract read
In one paragraph

Article in Cancer discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 8 institutions in 3 countries.

Weihua ZhouDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0259-0828
Zitong ZhaoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0005-5860-1559
Angelica LinDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0007-6217-673X
John Z YangDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0006-0758-0249
Jie XuDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0001-8676-6175
Kari Wilder-RomansDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-1468-1508
Annabel YangDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0005-7595-6001
Jing LiCell Signaling Technology, Inc., Danvers, Massachusetts.ORCID 0009-0009-6460-9871
Sumeet SolankiDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-2773-3082
Jennifer M SpethDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-7724-6995
Natalie WalkerDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-7445-3534
Andrew J ScottDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-0835-4888
Lu WangDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0007-8928-0326
Bo WenDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8337-220X
Anthony AndrenDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-0385-527X
Li ZhangDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-0703-7506
Ayesha U KothariDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-1996-1891
Yangyang YaoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0005-5540-3098
Erik R PetersonDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-6579-2948
Navyateja KorimerlaDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0005-0537-3724
Christian K WernerDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-7496-3617
Alexander UllrichDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-3720-1212
Jessica LiangDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0007-9127-2288
Janna JacobsonDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0008-9751-7458
Sravya PalavalasaDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5276-3972
Alexandra M O'BrienDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0001-1488-6688
Ameer L ElaimyDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0009-0094-921X
Sean P FerrisDepartment of Pathology, Division of Neuropathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5407-7212
Shuang G ZhaoDepartment of Human Oncology, University of Wisconsin Madison, Massachusetts.ORCID 0000-0002-9166-6507
Jann N SarkariaMayo Clinic, Rochester, Minnesota.ORCID 0000-0001-7489-4885
Balázs GyőrffyDepartment of Bioinformatics, Semmelweis University, Budapest, Hungary.ORCID 0000-0002-5772-3766
Shuqun ZhangDepartment of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, PR China.ORCID 0000-0002-6998-7849
Wajd N Al-HolouDepartment of Neurosurgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-8528-4855
Yoshie UmemuraDepartment of Neurology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-7137-661X
Meredith A MorganDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-7965-6878
Theodore S LawrenceDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-4186-8821
Costas A LyssiotisDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9309-6141
Marc Peters-GoldenDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9768-0262
Yatrik M ShahDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-2487-4816
Daniel R WahlDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9894-5085
University of Michigan · USMichigan Medicine · USCell Signaling Technology (United States) · USMayo Clinic · USNanchang University · CNSecond Affiliated Hospital of Xi'an Jiaotong University · CNSemmelweis University · HUUniversity of Wisconsin–Madison · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Translational Pathology CoreP50CA269022 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE, Meredith A Morgan · 2023 to 2026
$10.0M
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and FibrosisR35HL144979 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERS-GOLDEN, MARC L · 2019 to 2025
$6.5M
Control of iron absorption by intestinal HIF2 in iron and hematological disordersR01DK095201 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2012 to 2025
$5.7M
The role of HIF2alpha in colon carcinogenesisR01CA148828 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2010 to 2025
$5.2M
Targeting Nucleotide Metabolism to Overcome Therapy Resistance in GlioblastomaR37CA258346 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Daniel R Wahl · 2021 to 2026
$3.3M
Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic CancerR37CA237421 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Costas Andreas Lyssiotis · 2020 to 2026
$2.6M
Inhibition of wild-type IDH1 as a ferroptosis-inducing therapeutic approach for the treatment of malignant glioma.R01NS129123 · NINDS · WASHINGTON UNIVERSITY · PI Alexander H. Stegh, Daniel R Wahl · 2022 to 2026
$2.4M
Understanding the mechanisms of iron addiction in colon cancerR01CA245546 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2020 to 2024
$2.3M
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancerR01CA240515 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORGAN, MEREDITH A · 2020 to 2024
$2.2M
Stromal metabolism promotes therapeutic resistance in pancreatic cancerR01CA248160 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$2.0M
Targeting metabolic stress to induce pancreatic tumor cell deathR01CA244931 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$1.9M
NCI NIH HHS F32 CA260735NCI NIH HHS K08 CA234416NCI NIH HHS L30 CA209251NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA269022NCI NIH HHS R01 CA148828NCI NIH HHS R01 CA240515NCI NIH HHS R01 CA244931NCI NIH HHS R01 CA245546NCI NIH HHS R01 CA248160NCI NIH HHS R37 CA237421NCI NIH HHS R37 CA258346NHLBI NIH HHS R35 HL144979NIDDK NIH HHS R01 DK095201NINDS NIH HHS R01 NS129123
6 · The paper itself

Abstract

How cell metabolism regulates DNA repair is incompletely understood. Here, we define a GTP-mediated signaling cascade that links metabolism to DNA repair and has significant therapeutic implications. GTP, but not other nucleotides, regulates the activity of Rac1, a guanine nucleotide-binding protein, which promotes the dephosphorylation of serine 323 on Abl-interactor 1 (Abi-1) by protein phosphatase 5 (PP5). Dephosphorylated Abi-1, a protein previously not known to activate DNA repair, promotes nonhomologous end joining. In patients and mouse models of glioblastoma, Rac1 and dephosphorylated Abi-1 mediate DNA repair and resistance to standard-of-care genotoxic treatments. The GTP-Rac1-PP5-Abi-1 signaling axis is not limited to brain cancer, as GTP supplementation promotes DNA repair and Abi-1-S323 dephosphorylation in nonmalignant cells and protects mouse tissues from genotoxic insult. This unexpected ability of GTP to regulate DNA repair independently of deoxynucleotide pools has important implications for normal physiology and cancer treatment. SIGNIFICANCE: A newly described GTP-dependent signaling axis is an unexpected link between nucleotide metabolism and DNA repair. Disrupting this pathway can overcome cancer resistance to genotoxic therapy while augmenting it can mitigate genotoxic injury of normal tissues. This article is featured in Selected Articles from This Issue, p. 5.

Indexed as

GlioblastomaSignal TransductionAnimalsDNA DamageDNA RepairGuanosine TriphosphateHumansMiceGuanosine Triphosphate

Identifiers

PMID37902550
PMCPMC10872631
OpenAlexW4388013820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.